Diagnostic Value of Event-Related Evoked Potentials N200 and P300 Subcomponents in Early Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment

Summary: Event-related potentials (ERPs) have a large application in the evaluation of cognitive processes, particularly in Alzheimer’s disease (AD). The aim of the present study was to evaluate the clinical relevance of event-related evoked potentials (N2 and P3 subcomponents) in early diagnosis of AD and mild cognitive impairment (MCI). We prospectively studied 60 subjects. They all underwent the following investigations: neurologic and neuropsychological examination; functional evaluation, i.e., ERPs; cerebral imagery (morphologic and functional). Subjects were classified into 3 groups: group 1: 30 dementia of Alzheimer type (NINCDS-ADRDA, DSM-IV criteria); group 2: 20 MCI; and group 3: 10 control subjects. ERPs were significantly different between the groups (AD, MCI, control subjects), with a marked increase of P3 latencies, particularly when compared with N2 latencies (P < 0.0001). Furthermore, sensitivity was 87% to 95% for the differentiation of AD patients from MCI and control subjects, using prolonged P3 latencies (specificity, 90% to 95%), whereas using N2 prolonged latencies, sensitivity was 70% to 75% (specificity, 70% to 90%). Moreover, in the MCI group, N2 latencies strongly discriminated MCI from control subjects, with 90% sensitivity and 70% specificity and correctly categorized 80% of MCI subjects against 73% for P3. The abnormalities of N2 and P3 components may be linked, in AD and MCI, to an alteration of automatic and controlled attention processing.

[1]  Henry A. Nasrallah,et al.  Evoked potentials in subjects at risk for Alzheimer's Disease , 1995, Psychiatry Research.

[2]  H. Bokura,et al.  Event-related potentials for response inhibition in Parkinson's disease , 2005, Neuropsychologia.

[3]  A. Baddeley,et al.  Attentional control in Alzheimer's disease. , 2001, Brain : a journal of neurology.

[4]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[5]  M. Morales-Rodríguez,et al.  [Neurophysiological study and use of P300 evoked potentials for investigation in the diagnosis and of follow-up of patients with Alzheimer s disease]. , 2001, Revista de neurologia.

[6]  B. Dubois,et al.  Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. , 2004, Archives of neurology.

[7]  R H Logie,et al.  Theoretical and practical implications of dual-task performance in Alzheimer's disease. , 2001, Brain : a journal of neurology.

[8]  A. Revonsuo,et al.  Does P3 reflect attentional or memory performances, or cognition more generally? , 2000, Scandinavian journal of psychology.

[9]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[10]  K. Squires,et al.  Long latency event-related components of the auditory evoked potential in dementia. , 1978, Brain : a journal of neurology.

[11]  A. Pfeffer,et al.  Magnetic Resonance Imaging-Based Hippocampal Volumetry in Patients with Dementia of the Alzheimer Type , 1999, Dementia and Geriatric Cognitive Disorders.

[12]  C. Golden,et al.  Identification of brain disorders by the Stroop Color and Word Test. , 1976, Journal of clinical psychology.

[13]  J. Ford,et al.  Clinical application of the P3 component of event-related potentials. II. Dementia, depression and schizophrenia. , 1984, Electroencephalography and clinical neurophysiology.

[14]  M. Hansenne.  Le potentiel évoqué cognitif P300 (II) : variabilité interindividuelle et application clinique en psychopathologie , 2000, Neurophysiologie Clinique/Clinical Neurophysiology.

[15]  J. Pellet,et al.  [Description of a sample of 300 MADRS scales on depressive patients]. , 1987, Annales medico-psychologiques.

[16]  D. Brandee,et al.  EVENT-RELATED POTENTIALS OF THE BRAIN AND COGNITIVE PROCESSES: APPROACHES AND APPLICATIONS , 1986 .

[17]  Martial Van der Linden,et al.  L'épreuve de rappel libre / rappel indicé à 16 items (RL/RI-16) , 2004 .

[18]  M. Hansenne,et al.  [The p300 cognitive event-related potential. II. Individual variability and clinical application in psychopathology]. , 2000, Neurophysiologie clinique = Clinical neurophysiology.

[19]  K. Ritchie,et al.  The detection of mild cognitive impairment in the general practice setting , 2003, Aging & mental health.

[20]  E. John,et al.  Evoked-Potential Correlates of Stimulus Uncertainty , 1965, Science.

[21]  Maria Victoria Sebastian,et al.  Attentional Dysfunction of the Central Executive in Ad: Evidence from Dual Task and Perseveration Errors , 2006, Cortex.

[22]  S. Gauthier,et al.  Mild cognitive impairment is not a clinical entity and should not be treated. , 2005, Archives of neurology.

[23]  H. Möller,et al.  Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. , 2004, Molecular psychiatry.

[24]  Frank Padberg,et al.  Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease. , 2002, Psychophysiology.

[25]  D. Blackwood,et al.  The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials. , 2008, Journal of mental deficiency research.

[26]  R. Petersen,et al.  Aging, Memory, and Mild Cognitive Impairment , 1997, International Psychogeriatrics.

[27]  Edward J Golob,et al.  Auditory event-related potentials during target detection are abnormal in mild cognitive impairment , 2002, Clinical Neurophysiology.

[28]  S. Kindermann,et al.  Executive functions and P300 latency in elderly depressed patients and control subjects. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[29]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[30]  M. Rowan,et al.  Prognostic value of electrophysiological markers in Alzheimer's disease. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  Jaime Kulisevsky,et al.  Usefulness of P300 in Subjective Memory Complaints: A Prospective Study , 2005, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[32]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[33]  H. Soininen,et al.  MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.

[34]  M Hansenne.  [The p300 cognitive event-related potential. I. Theoretical and psychobiologic perspectives]. , 2000, Neurophysiologie clinique = Clinical neurophysiology.

[35]  D. Goodin,et al.  The distinction between different types of dementia using evoked potentials. , 1987, Electroencephalography and clinical neurophysiology. Supplement.

[36]  D. Anchisi,et al.  Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD , 2006, Neurobiology of Aging.

[37]  M. Albert,et al.  Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. , 1994, Archives of neurology.

[38]  J. Polich,et al.  Neuropsychology and neuropharmacology of P3a and P3b. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[39]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[40]  M. Hansenne,et al.  Le potentiel évoqué cognitif P300 (I) : aspects théorique et psychobiologique , 2000, Neurophysiologie Clinique/Clinical Neurophysiology.